News 13/14

NOVARTIS RELEASE MULTIPLE TRIAL RESULTS OF COSENTYX IN JUNE

ipharmaservices

Jun 30, 2019

Dupixent approved for chronic rhinosinusitis with nasal polyposis in United States

ipharmaservices

Jun 29, 2019

Pfizer’s receives approval for Avastin’s biosimilar from FDA

ipharmaservices

Jun 28, 2019

FDA approved AMAG Pharmaceuticals’ Vyleesi, expanded the indication of Symdeko for patients with CF

ipharmaservices

Jun 23, 2019

Roche’s Rozlytrek approved for the NTRK fusion-positive advanced recurrent solid tumors in Japan

ipharmaservices

Jun 23, 2019

Pfizer’s Talzenna was approved in Europe for the treatment of inherited BRCA-Mutated breast cancer

ipharmaservices

Jun 23, 2019

Novo Nordisk’s Esperoct approved for hemophilia in European Union

ipharmaservices

Jun 21, 2019

New guidance issued by CMC to safeguard and maintain the integrity of Medicaid enrollees

ipharmaservices

Jun 21, 2019

Janssen reports Phase 3 trials of Tremfya in adult patients with psoriatic arthritis

ipharmaservices

Jun 16, 2019

GSK and University of California collaborate to conduct advanced genomic research

ipharmaservices

Jun 14, 2019

EULAR 2019 updates

ipharmaservices

Jun 13, 2019

Genentech Rituxan (rituximab) PEMPHIX trail showed superiority over SoC in Pemphigus Vulgaris

ipharmaservices

Jun 13, 2019

US FDA approved Merck's Keytruda for two more target populations in patients suffering from HNSCC

ipharmaservices

Jun 12, 2019

WORLD CONGRESS OF DERMATOLOGY, MILAN, 2019

ipharmaservices

Jun 12, 2019

Genentech’s Polivy gets accelerated approval from the US FDA for patients with lymphoma

ipharmaservices

Jun 11, 2019

Merck to acquire privately held biopahrmaceutical company Tilos Therapeutics

ipharmaservices

Jun 10, 2019

ADA 2019 CONFERENCE UPDATES

ipharmaservices

Jun 9, 2019

US FDA and EMA approved Celgene’s ozanimod review application for treating Relapsing MS

ipharmaservices

Jun 6, 2019

Eli Lilly’s Emgality approved by US FDA for the treatment of episodic cluster headache

ipharmaservices

Jun 6, 2019

Novartis presented the histology data of iscalimab in patients underwent transplantation

ipharmaservices

Jun 4, 2019